Afinitor Approved In Europe For Advanced Breast Cancer
E.U. approval has been granted to Novartis drug Afinitor® (everolimus) after successful completion of the Phase III BOLERO-2 (Breast cancer trials of OraL EveROlimus-2) trial...Allergy Sufferers Have Lower Risk Of Brain Tumors Swine Flu And Agricultural Fairs, CDC Issue Precaution
